A synthetic peptide for use as a blocking control in assays to test for specificity of C19 orf62 antibody, Alternative Names: C19ORF62 control peptide, C19ORF62 antibody Blocking Peptide, Anti-C19ORF62 Blocking Peptide, FLJ20571 Blocking Peptide, HSPC142 Blocking Peptide
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
BRISC and BRCA1 A Complex Member 1 (BABAM1)
Hintergrund
C19orf62 is a component of the BRCA1-A complex, a complex that specifically recognises 'Lys-63'-linked ubiquitinated histones H2A and H2AX at DNA lesions sites, leading to target the BRCA1-BARD1 heterodimer to sites of DNA damage at double-strand breaks (DSBs).